News

As per the agreement, both the companies will identify glycans, the complex carbohydrate component of glycoproteins, which is believed to play a role in health and disease. Ezose’s

ALS-2200 and ALS-2158 are pan-genotypic nucleotide analogues, designed to inhibit the replication of the hepatitis C virus by acting on the NS5B polymerase. The two Phase 1 studies

Integrase inhibitors interfere with HIV replication by blocking the ability of the virus to integrate into the genetic material of human cells. The Phase 3 Study, Study 145

IBM has collaborated with AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer, to provide a database of over 2.4 million chemical compounds extracted from about 4.7 million patents and 11

The test identifies the primary origin of many types of tumors of uncertain or unknown origin and facilitates physicians by confirming suspected origins, or providing possible new origins

According to the company, MyPRS Plus helps gain further insights of individual’s genetic characteristics and also determines the molecular sub-group to which each patient belongs. The relapse and

The drug is indicated in conjunction with a mildly hypocaloric diet for the treatments of obese patients with associated risk factors. Teva Commercial Director Kim Innes said they

Arhalofenate is a uricosuric agent, when used in combination with xanthine oxidase inhibitors could be a treatment option for patients with tophaceous gout, a chronic, progressive rheumatic disease.

The partnership designates IGI as the developer and manufacturer of a family of prescription topical drug products owned by Medimetriks. In addition, as part of this long term